The spread of coronavirus disease 2019 (COVID-19) throughoutthe globe has forced a change in how routine medicalcare is delivered. Patients with heart failure (HF) alongsidethose with other cardiovascular co-morbidities are atincreased risk of morbidity and mortality from COVID-19.1,2In Mainland China, the case fatality rate for patients withcardiovascular disease was 10.5%, with 4.2% of cardiovasculardisease cases comprising 22.7% of all deaths.3,4 This hasresulted in a move to reduce in-person evaluation (IPE), astravel to hospitals and other healthcare facilities poses a riskto patients in contracting the disease. At the same time,because of increased inpatient workload, healthcare professionalsare being redeployed from commitments in ambulatorysettings to cope with patients admitted with COVID-19,forcing cardiologists to increase the capacity of their virtualclinics to manage patients from afar.
展开▼
